AuditLine › HHS OIG › Food and Drug Administration
HHS OIG recommendation 20-E-01-044.03
FDA should enhance its Risk Evaluation and Mitigation Strategy (REMS) assessment review process.
The recommendation, in the publisher's words
FDA should enhance its Risk Evaluation and Mitigation Strategy (REMS) assessment review process.
- Responsible agency
- Food and Drug Administration
- Issued
- September 25, 2020
- Report
- FDA's Risk Evaluation and Mitigation Strategies: Uncertain Effectiveness in Addressing the Opioid Crisis (OEI-01-17-00510) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Concur (as recorded by the publisher)
- Closed
- March 31, 2025 (publisher's date)
- Publisher topics
- Food; Drug and Device Safety, Prescription Drug, Public Health Issues, Substance Abuse Disorder
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
3 more, of which 0 are open in the publisher's file.
- FDA should use the new TIRF Risk Evaluation and Mitigation Strategy (REMS) patient registry to monitor for known areas of risk, such as inappropriate conversions and off-label prescribing.HHS OIG 20-E-01-044.01 · issued Sep 25, 2020 · closed Apr 17, 2024Closed Implemented
- FDA should strengthen the Risk Evaluation and Mitigation Strategy (REMS) for opioid analgesics (the successor to ER/LA opioids) by requiring prescriber training.HHS OIG 20-E-01-044.02 · issued Sep 25, 2020 · closed Apr 17, 2024Closed Acceptable Alternative
- FDA should seek additional authority to ensure that manufacturers are held accountable when appropriate.HHS OIG 20-E-01-044.04 · issued Sep 25, 2020 · closed Mar 31, 2025Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.